GU Special Issue | CURE

October 01, 2017

UNTIL ONCOLOGISTS ARE ABLE to cure every case of bladder cancer, treatment won’t rise to the level we envision. But the development of therapies for people with the disease is moving in the right direction — and remarkably swiftly.

September 22, 2017

Cancergraph, a smartphone app, helps patients track their symptoms and report them to doctors.

September 20, 2017

A clinical trial will test whether partial prostate ablation matches radical prostatectomy in effectiveness — with fewer early side effects.

September 20, 2017

After a drop, the frequency of PSA screening for prostate cancer has stabilized.

September 19, 2017

A targeted drug for women with ovarian cancer may also benefit men with prostate cancer who have similar genetic mutations. A phase 3 trial is designed to find out.

September 19, 2017

Study: To prolong survival in early-stage prostate cancer that is low-risk, observe instead of operating.

September 15, 2017

The latest drugs for advanced kidney cancer are stirring optimism.

September 15, 2017

Scientists are looking for more and better ways to identify the prostate cancers that are most likely to become aggressive.

September 14, 2017

Immunotherapies known as checkpoint inhibitors are so promising in bladder cancer that many patients want them as first treatments — before they’ve been proven in that setting.